Consolidated statements of income and comprehensive income/loss (-)
(unaudited)
|
Three months ended 31 March |
|
|---|---|---|
(thousands of €, except per share data) |
2022 |
2021 |
Product net sales |
14,411 |
79 |
Collaboration revenues |
121,936 |
113,813 |
Total net revenues |
136,347 |
113,892 |
|
|
|
Cost of sales |
(2,912) |
(38) |
Research and development expenditure |
(99,921) |
(129,960) |
Sales and marketing expenses |
(28,984) |
(14,536) |
General and administrative expenses |
(33,355) |
(30,422) |
Other operating income |
7,680 |
10,266 |
|
|
|
Operating loss |
(21,146) |
(50,798) |
|
|
|
Fair value re-measurement of warrants |
(185) |
1,970 |
Other financial income |
15,058 |
47,500 |
Other financial expenses |
(5,312) |
(11,345) |
|
|
|
Loss before tax |
(11,586) |
(12,673) |
Income taxes |
(1,724) |
(157) |
|
|
|
Net loss from continuing operations |
(13,310) |
(12,830) |
|
|
|
Net profit from discontinued operations, net of tax |
- |
22,191 |
|
|
|
Net profit/loss (-) |
(13,310) |
9,361 |
|
|
|
Net profit/loss (-) attributable to: |
|
|
Owners of the parent |
(13,310) |
9,361 |
Basic income/loss (-) per share |
(0.20) |
0.14 |
Diluted income/loss (-) per share |
(0.20) |
0.14 |
Basic and diluted loss per share from continuing operations |
(0.20) |
(0.20) |
The accompanying notes form an integral part of these condensed consolidated financial statements.
|
Three months ended 31 March |
|
|---|---|---|
(thousands of €) |
2022 |
2021 |
Net profit/loss (-) |
(13,310) |
9,361 |
Items that may be reclassified subsequently to profit or loss: |
|
|
Translation differences, arisen from translating foreign activities |
(19) |
298 |
Realization of translation differences upon sale of foreign operations |
- |
731 |
Other comprehensive income/loss (-), net of income tax |
(19) |
1,029 |
|
|
|
Total comprehensive income/loss (-) attributable to: |
|
|
Owners of the parent |
(13,329) |
10,390 |
|
|
|
Total comprehensive income/loss (-) attributable to owners of the parent arises from: |
|
|
Continuing operations |
(13,329) |
(12,532) |
Discontinued operations |
- |
22,922 |
Total comprehensive income/loss (-) |
(13,329) |
10,390 |
The accompanying notes form an integral part of these condensed consolidated financial statements.